Biodexa Pharmaceuticals (BDRX) News

Why Mission Produce Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket

Shares of Mission Produce Inc (NASDAQ:AVO) rose sharply in pre-market trading after the company posted better-than-expected third-quarter results.Mission Produce reported quarterly earnings of 18

BenzingaSep 9 16:39

12 Health Care Stocks Moving In Wednesday's Intraday Session

GainersBiohaven (NYSE:BHVN) shares increased by 16.5% to $16.75 during Wednesday's regular session. The market value of their outstanding shares is at $2.1 billion. SCYNEXIS (NASDAQ:SCYX) stock

BenzingaAug 27 01:06

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

GainersNuwellis (NASDAQ:NUWE) stock increased by 27.2% to $1.22 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.0 million. Summit Therapeutics (NASDAQ:

BenzingaAug 26 20:06

Why JOYY Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Shares of JOYY Inc (NASDAQ:JOYY) rose sharply in pre-market trading after the company reported financial results for the second quarter.JOYY reported quarterly earnings of $1.24 per share which

BenzingaAug 26 17:22

Why Cadeler Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Shares of Cadeler A/S – ADR (NYSE:CDLR) rose sharply in pre-market trading after the company reported interim financial results for the first half of 2026.Revenue for the first six months of 2026

BenzingaAug 25 17:25

US Stock Market Close | US Treasury intervenes to support long-term bonds, lifting all three major indices; Moderna surges, igniting a rally in the biopharmaceutical sector, with Merck & Co up over 12% and the S&P Biotechnology ETF rising nearly 6%; Bitco

The S&P 500 closed up 0.21% at 7,707.98, the Nasdaq Composite rose 0.16% to 26,331.09, and the Dow Jones Industrial Average gained 0.22% to 53,463.05, ending a three-day losing streak for all three major indices. Moderna surged 176.97% to hit a record high, while Merck & Co jumped 13%, leading the healthcare sector's gains in the S&P; meanwhile, semiconductor and AI momentum stocks suffered heavy losses, with chip ETFs falling a cumulative 7.7% over two days.

wallstreetcnAug 20 07:02

Biodexa Says 87 Of Planned 168 Subjects Recruited In Registrational Phase 3 Serenta Trial Of ERapa In Familial Adenomatous Polyposis

Biodexa Says 87 Of Planned 168 Subjects Recruited In Registrational Phase 3 Serenta Trial Of ERapa In Familial Adenomatous

BenzingaAug 19 20:33

Biodexa Announces Major Milestone for Its Serenta Registrational Phase 3 Trial in FAP

August 19, 2026 Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP 87 subjects, over 50% of target, recruited Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) ("Biodexa"

GlobeNewswireAug 19 20:30

Biodexa Pharmaceuticals Restructures Share Capital and Boosts Issuance Capacity After July 29 General Meeting

TipRanksJul 30 05:13

Result of General Meeting

July 29, 2026 Biodexa Pharmaceuticals PLC Result of General Meeting Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) ("Biodexa" or "the Company"), a clinical stage biopharmaceutical company developing

GlobeNewswireJul 30 04:30

Biodexa Pharmaceuticals Shares Are Trading Lower. The Company Announce That It Has Held Its First Round Table Meeting in Paris, France as Part of Expanding Its Support for Familial Adenomatous Polyposis Patients and Prescribers.

Biodexa Pharmaceuticals Shares Are Trading Lower. The Company Announce That It Has Held Its First Round Table Meeting in Paris, France as Part of Expanding Its Support for Familial Adenomatous

BenzingaJul 29 22:23

Biodexa Initiates Support Activities for FAP Patients and Treatment Centers in France

July 28, 2026 Biodexa Initiates Support Activities for FAP Patients and Treatment Centers in France Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing

GlobeNewswireJul 29 20:30

12 Health Care Stocks Moving In Thursday's After-Market Session

GainersTenet Healthcare (NYSE:THC) shares rose 14.1% to $227.06 during Thursday's after-market session. The company's market cap stands at $17.1 billion. As per the news, the Q2 earnings report came

BenzingaJul 24 05:06

12 Health Care Stocks Moving In Wednesday's After-Market Session

GainersZhengye Biotechnology (NASDAQ:ZYBT) shares moved upwards by 24.0% to $1.71 during Wednesday's after-market session. The market value of their outstanding shares is at $135.0 million. Medpace

BenzingaJul 23 05:05

Biodexa Pharmaceuticals Calls July 29 General Meeting to Overhaul Share Capital Structure

TipRanksJul 10 04:48

12 Health Care Stocks Moving In Thursday's Pre-Market Session

GainersLiminatus Pharma (NASDAQ:LIMN) stock increased by 40.9% to $0.16 during Thursday's pre-market session. The market value of their outstanding shares is at $5.8 million. Stablecoin Development (

BenzingaJul 2 20:05

Press Release: Result of Annual General Meeting

June 30, 2026 Biodexa Pharmaceuticals PLC ("Biodexa" or the "Company") Result of Annual General Meeting Biodexa Pharmaceuticals PLC (Nasdaq: BDRX) ("Biodexa" or "the Company"), a clinical stage

Dow JonesJul 1 04:30

Biodexa Raises $3.5 Million via Registered Offering, Private Placement and Warrant Inducement

TipRanksJun 30 21:52

6-K: Biodexa Pharmaceuticals | 6-K: Report of foreign private issuer (related to financial reporting)

SECJun 30 21:19

Biodexa Pharmaceuticals Shares Are Trading Lower After the Company Announced the Pricing of Its $3.5 Million Offering and Concurrent Private Placement of Pre-funded Warrants and Warrants.

Biodexa Pharmaceuticals Shares Are Trading Lower After the Company Announced the Pricing of Its $3.5 Million Offering and Concurrent Private Placement of Pre-funded Warrants and Warrants.

BenzingaJun 30 20:04